![]() |
시장보고서
상품코드
1559461
세계의 인공 견관절 치환술용 디바이스 - 시장 인사이트, 경쟁 구도, 시장 예측(-2030년)Shoulder Replacement Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
세계 인공 견관절 치환술용 디바이스 시장 규모는 2023년에 16억 8,000만 달러로 평가되었고 2030년까지 25억 4,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR) 7.27%의 성장이 예상됩니다. 시장은 어깨 부상이나 변형성 관절증이나 류마티스 관절염과 같은 퇴행성 질환의 광범위한 사례, 제품 개발과 혁신 활동 증가 등의 요인이 시장 성장에 기여해, 예측 기간 동안 큰 성장을 보여줍니다.
인공 견관절 치환술용 디바이스 시장 역학
National Institute of Health는 2022년 어깨 체인(AC) 관절 손상이 스포츠 선수와 청소년층에서 뚜렷하게 나타났으며 어깨 관절 손상의 40% 이상을 차지한다고 발표했습니다. 쇄골과 견갑골의 어깨봉이 접하는 AC 관절은 어깨를 안정시키는 역할과 강한 충격에 노출되기 때문에 특히 손상되기 쉽습니다. 이러한 손상은 종종 접촉 스포츠에서 흔히 볼 수 있는 넘어짐이나 충돌과 같은 직접적인 외상 또는 반복적인 스트레스로 인해 발생합니다. AC 관절 손상은 심각한 어깨 기능 장애로 이어지므로 어깨 관절 대체술은 환자에게 편안함을 제공하기 위해 수술 개입에 사용됩니다.
세계보건기구(WHO)(2023년)에 따르면 전 세계적으로 3억 4,400만 명이 골관절염을 앓고 있습니다. 이 인구 중 골관절염 환자의 73%는 55세 이상이고 60%는 여성입니다. 골관절염은 어깨 관절의 연골 파괴를 특징으로 하는 퇴행성 관절 질환으로 통증, 경직, 가동 영역의 감소를 초래합니다. 이 질환은 종종 관절에 큰 손상을 일으키며, 기능 회복과 증상 완화에 인공 견관절 치환술이 필요할 수 있습니다. 또한 같은 자료에 따르면 1,300만 명이 류마티스 관절염을 앓고 있습니다. 이 때문에 관절의 내벽이 염증을 일으켜 침식되어 연골과 뼈의 파괴가 진행됩니다. 인공 견관절 치환술(전체 치환 또는 부분 치환술)은 손상된 관절면을 인공 구성 요소로 대체하고 기능을 회복시키고 통증을 완화하기 위해 수행됩니다.
규제 당국에 의한 승인이나 우에시 등의 제품 개발 활동의 활성화도, 인공 견관절 치환술용 디바이스 시장 성장에 직면할 전망입니다. 예를 들어, 2021년 7월, Stryker는 어깨 관절의 연속 치료에서 갭을 메우는 최초의 생분해성 어깨봉하 풍선 스페이서, InSpace의 FDA 인가를 발표했습니다. 이 풍선 임플란트는 수리할 수 없는 심각한 힘줄 절단(MIRCT)의 관절경 시하 치료에 사용되는 최초의 제품이었습니다. InSpace는 외과의사에게 어깨 관절 치료의 새로운 옵션을 제공하여 환자의 요구에 더 정확하게 대응할 수있게했습니다.
이 외에도 2024년 5월 인공 견관절 임플란트 시장 리더인 Shoulder Innovations는 최신 제품인 InSet(TM) 95 Humeral Stem의 출시를 발표했습니다. InSet(TM) 95 Humeral Stem은 골질이 나쁜 환자의 수술 성과를 향상시키고 환자의 회복을 개선하기 위해 설계되었으며 독특한 2핀 디자인을 도입했습니다. 이 혁신적인 특징은 뛰어난 회전 제어와 안정성을 제공하기 위해 특별히 설계되었으며, 인공 견관절 대체술에서 정확한 임플란트 정렬과 최적의 생체 메커니즘을 가능하게합니다.
따라서 2024년부터 2030년까지의 예측 기간 동안 위의 모든 요인이 상호 작용하여 어깨 관절 치환술 장치 시장을 견인할 것으로 예측됩니다.
그러나 수술 중 신경과 혈관 손상, 인공 관절의 탈구 등이 인공 견관절 대체술 장치 시장의 성장을 억제할 수 있습니다.
인공 견관절 치환술용 디바이스 시장의 부문 분석
인공 견관절 시장의 유형 부문은 해부학적인 인공 견관절 카테고리가 2023년에 가장 큰 시장 수익 점유율을 차지할 것으로 예측됩니다. 이 카테고리의 급성장은 어깨 관절의 자연적인 구조를 재현하는 능력 때문입니다. 그 주요 특징은 어깨 관절의 볼과 소켓 구조를 재구성하여 관절의 정상적인 움직임과 생체 기계를 충실하게 재현합니다. 해부학적인 인공 견관절은 보통 관절와 맞는 상완두 구성요소를 포함하여 더 나은 정렬과 안정성을 촉진합니다. 탈구 위험 감소, 관절 안정성 향상, 수술 후 재활 개선 등의 이점이 있습니다. 이 접근법은 골관절염과 힘줄 찢어짐과 같은 어깨 본래의 기능을 가능한 한 유지하는 것이 중요한 질병을 가진 환자에게 특히 유용합니다.
이 보고서는 세계 인공 견관절 대체술 장치 시장에 대한 조사 분석을 통해 각 지역 시장 규모와 예측, 지난 3 년간의 제품/기술 개발, 각 부문의 성과 및 전망 등의 정보를 제공합니다.
Shoulder Replacement Devices market by Type (Anatomical Shoulder Prosthesis and Reverse Shoulder Prosthesis), Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Product (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), End-User (Hospitals, Clinics, and Outpatient Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the rising number of road accident cases and sports-related injuries involving the shoulder, and the rising product developmental activities across the globe
The shoulder replacement devices market was valued at USD 1.68 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 2.54 billion by 2030. The shoulder replacement devices market is experiencing significant growth owing to the widespread instances of shoulder injuries and degenerative conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, among others that are acting as key factors, contributing to the market growth of the shoulder replacement devices market during the forecast period from 2024 to 2030.
Shoulder Replacement Devices Market Dynamics:
The National Institute of Health in 2022 stated that acromioclavicular (AC) joint injuries are notably prevalent among athletes and young individuals, constituting over 40% of all shoulder injuries. The AC joint, where the clavicle (collarbone) meets the acromion of the scapula (shoulder blade), is particularly vulnerable due to its role in stabilizing the shoulder and its exposure to high-impact forces. These injuries often result from direct trauma, such as falls or collisions common in contact sports, or from repetitive stress. Since AC joint damage leads to significant shoulder dysfunction, shoulder replacement devices are utilized in surgical intervention to provide patient comfort.
According to the World Health Organization (2023), 344 million individuals are affected by osteoarthritis globally. Amongst this population, 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage in the shoulder joint, leading to pain, stiffness, and reduced range of motion. This condition often results in significant joint damage that may necessitate shoulder replacement surgery to restore function and alleviate symptoms. Moreover, as per the same source, 13 million people are living with rheumatoid arthritis. This causes the joint lining to become inflamed and eroded, leading to progressive destruction of the cartilage and bone. Shoulder replacement surgery, either total or partial, is used to replace the damaged joint surfaces with prosthetic components, restoring function and alleviating pain.
Increased product developmental activities such as approvals by the regulatory bodies and launches are also slated to witness the market growth of shoulder replacement devices. For example, in July 2021, Stryker announced the FDA clearance of the first biodegradable subacromial balloon spacer, InSpace, which filled a gap in the shoulder continuum of care. This balloon implant was the first of its kind for the arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs). InSpace provided surgeons with a new option in their shoulder continuum of care, enabling them to better address their patients' needs.
In addition to this, in May 2024, Shoulder Innovations, a leader in the shoulder replacement implant market, announced the launch of its latest product, the InSet(TM) 95 Humeral Stem. Designed to enhance surgical outcomes and improve patient recovery for individuals with poor bone quality, the InSet(TM) 95 Humeral Stem introduced a unique 2-fin design. This innovative feature was specifically engineered to provide superior rotational control and stability, allowing for precise implant alignment and optimal biomechanics in shoulder replacement surgery.
Hence, the interplay of all the above mentioned factors are expected to drive the market for shoulder replacement devices market during the given forecast period from 2024 to 2030.
However, nerves & blood vessel damage during surgery, dislocation of artificial joints, and others may restrain the growth of the shoulder replacement devices market.
Shoulder Replacement Devices Market Segment Analysis:
Shoulder Replacement Devices market by Type (Anatomical Shoulder Prosthesis and Reverse Shoulder Prosthesis), Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Product, (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), End-User (Hospitals, Clinics, and Outpatient Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the type segment of the shoulder replacement devices market, the anatomical shoulder prosthesis category of is predicted to account for the largest market revenue share in 2023. The rapid growth of this category can be attributed to its ability to replicate the natural structure of the shoulder joint. A key feature of this is the reconstruction of the ball-and-socket configuration of the shoulder, which closely replicates the normal movement and biomechanics of the joint. The anatomical prosthesis typically includes a humeral head component that fits into a glenoid socket, promoting better alignment and stability. Advantages include reduced risk of dislocation, enhanced joint stability, and improved post-operative rehabilitation. This approach is particularly beneficial for patients with conditions like osteoarthritis or rotator cuff tears, where preserving as much of the natural shoulder function as possible is crucial.
Furthermore, the growing technological advancements in this category by the market key players act as a major factor in boosting its market. For example, In January 2021, Boston Orthopaedic and Spine started offering Equinoxe Stemless Shoulder implant, which is a 3-D printed solution for people who needed shoulder reconstruction surgeries. The product is termed as a bone-conserving prosthesis suited for anatomic shoulder replacement and can deliver long-term fixation to the recipient's bone.
In addition to this, in May 2021, Olympus Corporation of the Americas announced the successful implementation of the 510(k) cleared e-ORTHO Shoulder software, developed by FH ORTHO. This milestone involved an Arrow Prime shoulder replacement procedure, utilizing the advanced e-ORTHO 3D planning software for preoperative surgical technique planning. This innovative software represents a significant advancement in surgical planning technology.
Therefore, the presence of a robust product portfolio for the anatomical shoulder prosthesis category with a wide range of features and applications is expected to witness considerable growth, eventually contributing to the growth of the overall shoulder replacement devices market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall shoulder replacement devices market:
Among all the regions, North America is expected to amass the largest share of the shoulder replacement devices market. This can be ascribed to the increasing instances of shoulder injuries and fractures, the increasing focus on research and development activities, presence of key market players holding high revenue shares in the region, and advanced healthcare infrastructure. Together these factors are driving the need of shoulder replacement devices during the forecast period from 2024 to 2030.
According to the American Academy of Orthopaedic Surgeons (2024), in 2021 more than 100,000 shoulder replacement surgeries are performed annually in the U.S., encompassing total shoulder replacement, hemiarthroplasty, and reverse total shoulder replacement. As per the same source it projects that by 2025, the number of shoulder replacement procedures in the U.S. could range between 174,000 and 350,000.
As per data from the American Academy of Physical Medicine and Rehabilitation (2022), in the US, the incidence of shoulder dislocations is approximately 23.9 per 100,000 person-years, with 85-98% of these being anterior dislocations. The frequency of proximal humerus fractures rises with age, increasing by about 15% per year, and these fractures often become more complex in older individuals. Among those over 65 years old, the incidence of humeral fractures is 101 per 100,000 person-years. Clavicle fractures represent about 2.6% to 10% of all fractures across various sports, with a global incidence ranging from 17.4 to 91 per 100,000 person-years. Acromioclavicular joint separations account for 9-12% of shoulder girdle injuries, with Type I and II separations being the most common. These injuries are predominantly seen in contact sports and occur most frequently in young males aged 20 to 30 years.
Thus, the increasing incidence of shoulder injuries and fractures, coupled with the projected rise in shoulder replacement procedures, underscores the growing demand for shoulder replacement devices, thereby driving significant market growth.
The product developmental activities by the regulatory bodies in the region also push forward the revenue shares of shoulder replacement devices. For example, in 2024, Zimmer Biomet received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ROSA Shoulder System, a robotic assistant designed to aid in shoulder replacement surgeries. This advanced system supports surgeons in performing total shoulder replacements using both anatomic and reverse techniques.
Thus, all the factors mentioned above promote a conducive environment for the shoulder replacement devices market during the forecast period from 2024 to 2030.
Shoulder Replacement Devices Market key players:
Some of the key market players operating in the Shoulder Replacement Devices market include Wright Medical Group, Inc., /Tornier Inc, Integra LifeSciences Corporation, Zimmer Biomet, Johnson & Johnson Services, Inc, Arthrex, Inc, Smith and Nephew Plc, Conmed Corporation, DJO Global, Evolutis, Exactech, Inc, Stryker Corporation, Limacorporate S.p.A., B. Braun Melsungen AG, Elite Surgical, Baumer, and others.
Recent Developmental Activities in the Shoulder Replacement Devices Market:
Key Takeaways from the Shoulder Replacement Devices Market Report Study
Target audience who can be benefited from this Shoulder Replacement Devices Market Report Study
Frequently Asked Questions for the Shoulder Replacement Devices Market:
Shoulder replacement devices are surgical implants used to replace damaged or diseased components of the shoulder joint. They are typically employed in procedures known as shoulder arthroplasty. These devices help restore function and alleviate pain in patients with conditions such as severe arthritis, rotator cuff tears, or fractures.
The shoulder replacement devices market was valued at USD 1.68 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 2.54 billion by 2030.
The shoulder replacement devices market is experiencing significant growth, owing to the widespread instances of shoulder injuries and degenerative conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, and among others are acting as key factors is contributing to market growth of the shoulder replacement devices market during the forecast period from 2024 to 2030.
Some of the key market players operating in the shoulder replacement devices market include Wright Medical Group, Inc., /Tornier Inc, Integra LifeSciences Corporation, Zimmer Biomet, Johnson & Johnson Services, Inc, Arthrex, Inc, Smith and Nephew Plc, Conmed Corporation, DJO Global, Evolutis, Exactech, Inc, Stryker Corporation, Limacorporate S.p.A., B. Braun Melsungen AG, Elite Surgical, Baumer, and others.
Among all the regions, North America is estimated to hold a significant revenue share in the shoulder replacement devices market. This can be ascribed to the increasing instances of shoulder injuries and fractures, the increasing focus on research and development activities, presence of key market players holding the high revenue shares in the region and advance healthcare infrastructure. Together these factors are driving the need of shoulder replacement devices during the forecast period from 2024 to 2030.